The Discounted Cash Flow (DCF) valuation of Eagle Pharmaceuticals Inc (EGRX) is 42.36 USD. With the latest stock price at 3.73 USD, the upside of Eagle Pharmaceuticals Inc based on DCF is 1037.1%.
Based on the latest price of 3.73 USD and our DCF valuation, Eagle Pharmaceuticals Inc (EGRX) is a buy. buying EGRX stocks now will result in a potential gain of 1037.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.4% | 7.4% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 35.06 - 53.52 | 42.36 |
| Upside | 841.1% - 1336.8% | 1037.1% |